Chongqing Pharscin Pharmaceutical Co (SZSE:002907) LT-Debt-to-Total-Asset : 0.00 (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Chongqing Pharscin Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Chongqing Pharscin Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Sep. 2024 was 0.00.

Chongqing Pharscin Pharmaceutical Co's long-term debt to total assets ratio stayed the same from Sep. 2023 (0.00) to Sep. 2024 (0.00).

Chongqing Pharscin Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Chongqing Pharscin Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Pharscin Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Chongqing Pharscin Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.14

Chongqing Pharscin Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Chongqing Pharscin Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Chongqing Pharscin Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0.14	/	1851.454
	=	0.00

Chongqing Pharscin Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2024 is calculated as

LT Debt to Total Assets (Q: Sep. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2024 )	/	Total Assets (Q: Sep. 2024 )
	=	0.045	/	1911.716
	=	0.00

Chongqing Pharscin Pharmaceutical Co (SZSE:002907) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Chongqing Pharscin Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Chongqing Pharscin Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Pharscin Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chongqing Pharscin Pharmaceutical Co Ltd (SZSE:002907) » Definitions » LT-Debt-to-Total-Asset

Traded in Other Exchanges

N/A

Address

No. 89, Middle Section of Huangshan Avenue, Yubei District, Chongqing, CHN, 401120

Website

http://www.pharscin.com

Chongqing Pharscin Pharmaceutical Co Ltd is a China-based pharmaceutical research and development company. It produces and sells medicines in form of tablets, powders, granules, hard capsules, soft capsules, powder injection, freeze-dried powder injection, small volume injection, raw material synthesis and botanical extracts. It operates internationally.

Executives

Deng Zhi Chun	Supervisors
Wang Ying	Directors, executives
Peng Xiao Yan	Executives
You Hong Tao	Director
Liu Xiao Ying	Directors, executives
You Yong Dong	Director

Chongqing Pharscin Pharmaceutical Co Headlines

No Headlines